fbpx

The Nike Athena and Nike Zeus Sunglasses Give Athletes a Competitive Edge

Look good. Feel good. Compete at your peak.

That’s the attitude behind the Nike Athena and Nike Zeus sunglasses, intended to be worn before and after competition as a form of psychological armor — whether to protect or project.

“While we were initially focused on designing something for competition, the insight we heard from our athletes is the need for a mental edge or advantage, before and after competing. Their ability to get totally into the zone, to be completely focused and undistracted, is so, so critical for these athletes.”

John Hoke, Nike Chief Innovation Officer

The futuristic, all-gender Nike Athena and Nike Zeus sunglasses push that insight to the cutting edge, setting athletes apart from their competitors while expressing their personalities. The styles usher in a new level of digital artistry in service of athletes, advancing Nike’s aesthetic horizons while offering contrasting visions of sport’s future.

NIKE Athena
NIKE Athena

Nike Athena is a celebration of asymmetry and expression, with mirroring that wraps from lens to temple, punctuated by Nike’s Electric Pack graphic. Screwless, ultrasonic bonds and stainless-steel temples (or arms) contribute to a lightweight frame, which positions the lens further from the face to help eliminate the “lash crash” sometimes caused by shallower sunglasses.

NIKE Zeus
NIKE Zeus

Nike Zeus, meanwhile, has an angular, technical appearance. Inspired by traditional acupressure points and the look of “speed” — an enduring Nike fixation — the design suspends five translucent elements in an ultralightweight, handcrafted titanium frame. Mask-like and worn close to the face, Nike Zeus builds on the innovative ventilation of the Nike Windshield Elite 360, with intricate, fluted perforations increasing airflow to help eliminate heat pockets around the nose and cheekbones while directing heat away from the eyes.

Both styles employ Nike Max Extreme Lens technology for maximum optical clarity and reduced eye fatigue on track, field and road surfaces. They also incorporate recycled materials; at least 40% of Nike Athena’s total weight and 20% of Nike Zeus.

The Nike Athena and Nike Zeus eyewear are now available globally on Nike digital platforms.

Click HERE for the press release.

Want to see more like this article? Click here to subscribe to our FREE print magazines and e-newsletters!

Featured Posts

Canadian Optical Supply Announces Passing of Co-founder Judith Hochstadter

Judith Hochstadter, co-founder of Canadian Optical Supply (COS) together with her late husband, Fred, passed away Saturday, September 7, 2024.

Learn More
MIDO Square

MIDO | Milano Eyewear Show Announces New Dates for 2026 Edition

The trade show will take place January 31 to February 2 to avoid overlapping the Milano Cortina 2026 Winter Olympic Games.

Read more
Fighting Blindness Canada research

First Patients Treated in XLRP Gene Therapy Trial

Beacon Therapeutics, has announced that they have treated the first patients in their Phase 2/3 VISTA trial for a gene therapy for X-linked retinitis pigmentosa (XLRP).

Read more
CooperCompanies

CooperCompanies Recognized as a Best Workplace for Innovators

Leading global medical device company recognized for culture that drives innovation for customers and patients.

Read more
Nikon Optical Canada logo

Nikon Optical Unveils “Vision You Can Feel” Campaign in Canada

Nikon Optical Canada announces its launch of the 2024 brand campaign, Vision You Can Feel.

Read more

Canadian Optical Supply Announces Passing of Co-founder Judith Hochstadter

Judith Hochstadter, co-founder of Canadian Optical Supply (COS) together with her late husband, Fred, passed away Saturday, September 7, 2024.

Learn More
MIDO Square

MIDO | Milano Eyewear Show Announces New Dates for 2026 Edition

The trade show will take place January 31 to February 2 to avoid overlapping the Milano Cortina 2026 Winter Olympic Games.

Read More
Fighting Blindness Canada research

First Patients Treated in XLRP Gene Therapy Trial

Beacon Therapeutics, has announced that they have treated the first patients in their Phase 2/3 VISTA trial for a gene therapy for X-linked retinitis pigmentosa (XLRP).

Read More
CooperCompanies

CooperCompanies Recognized as a Best Workplace for Innovators

Leading global medical device company recognized for culture that drives innovation for customers and patients.

Read More
Nikon Optical Canada logo

Nikon Optical Unveils “Vision You Can Feel” Campaign in Canada

Nikon Optical Canada announces its launch of the 2024 brand campaign, Vision You Can Feel.

Read More

Canadian Optical Supply Announces Passing of Co-founder Judith Hochstadter

Judith Hochstadter, co-founder of Canadian Optical Supply (COS) together with her late husband, Fred, passed away Saturday, September 7, 2024.

Learn More
MIDO Square

MIDO | Milano Eyewear Show Announces New Dates for 2026 Edition

The trade show will take place January 31 to February 2 to avoid overlapping the Milano Cortina 2026 Winter Olympic Games.

Read more
Fighting Blindness Canada research

First Patients Treated in XLRP Gene Therapy Trial

Beacon Therapeutics, has announced that they have treated the first patients in their Phase 2/3 VISTA trial for a gene therapy for X-linked retinitis pigmentosa (XLRP).

Read more
CooperCompanies

CooperCompanies Recognized as a Best Workplace for Innovators

Leading global medical device company recognized for culture that drives innovation for customers and patients.

Read more
Nikon Optical Canada logo

Nikon Optical Unveils “Vision You Can Feel” Campaign in Canada

Nikon Optical Canada announces its launch of the 2024 brand campaign, Vision You Can Feel.

Read more

Canadian Optical Supply Announces Passing of Co-founder Judith Hochstadter

Judith Hochstadter, co-founder of Canadian Optical Supply (COS) together with her late husband, Fred, passed away Saturday, September 7, 2024.

Learn More
MIDO Square

MIDO | Milano Eyewear Show Announces New Dates for 2026 Edition

The trade show will take place January 31 to February 2 to avoid overlapping the Milano Cortina 2026 Winter Olympic Games.

Read more
Fighting Blindness Canada research

First Patients Treated in XLRP Gene Therapy Trial

Beacon Therapeutics, has announced that they have treated the first patients in their Phase 2/3 VISTA trial for a gene therapy for X-linked retinitis pigmentosa (XLRP).

Read more
CooperCompanies

CooperCompanies Recognized as a Best Workplace for Innovators

Leading global medical device company recognized for culture that drives innovation for customers and patients.

Read more
Nikon Optical Canada logo

Nikon Optical Unveils “Vision You Can Feel” Campaign in Canada

Nikon Optical Canada announces its launch of the 2024 brand campaign, Vision You Can Feel.

Read more